Work

Nanocarrier-encapsulated SGLT-2 inhibitor (dapagliflozin) protects against diabetic cardiomyopathy by reducing myocardial fibrosis

Year: 2025

Type: article

Abstract: European Cells & Materials Journal - Open and Free Access - The Official Research Journal of AOCMF, AOTrauma, European Orthopaedic Research Society (EORS), Swiss Society for Biomaterials (SSB) and Tissue & Cell Engineering Society (TCES)

Source: European Cells and Materials

DOI: 10.22203/ecm.v050a02

Authors: CY Li, F Xu, LR Zhu, C Cheng, JY Kuang, T Zhao

Language: English

Topic: Cardiac Fibrosis and Remodeling

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,000

OpenAlex ID: W4409309687

FWCI: 11.32

Cites:

Cited by: 18

Related to: 10